Premium
Marginal zone lymphoma with a dual cutaneous and leukemic presentation and an aberrant myeloid‐monocytic phenotype
Author(s) -
Keehn Connie A,
Cualing Hernani
Publication year - 2006
Publication title -
journal of cutaneous pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 75
eISSN - 1600-0560
pISSN - 0303-6987
DOI - 10.1111/j.0303-6987.2006.00407.x
Subject(s) - marginal zone , lymphoma , pathology , phenotype , myeloid , bone marrow , lymphatic system , marginal zone b cell lymphoma , medicine , biology , cancer research , b cell , immunology , antibody , gene , biochemistry
Marginal zone lymphoma (MZL) is an indolent neoplasm of mature B cells, classified by the World Health Organization into three categories: nodal, splenic, and extranodal MZL of mucosa‐associated lymphoid tissue (MALT lymphoma). We present an unusual case of MZL with cutaneous, leukemic, and bone marrow involvement at presentation and expression of an aberrant myeloid‐monocytic phenotype. This case is best classified as MZL of leukemic subtype.